Research Progress of Butyrate-producing Bacteria in Regulating Intestinal Microecology and Interventional Effect of Chinese Herbal Medicine

Zhen-yuan XU; Xiao-ya LI; Ya-qing XU; Bo QIAO; Jing CHEN; Jia-li YUAN

doi:10.13422/j.cnki.syfjx.20200307

您当前的位置：

首页 >

文章列表页 >

Research Progress of Butyrate-producing Bacteria in Regulating Intestinal Microecology and Interventional Effect of Chinese Herbal Medicine

Review | 更新时间：2021-02-09

- Research Progress of Butyrate-producing Bacteria in Regulating Intestinal Microecology and Interventional Effect of Chinese Herbal Medicine
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 6, Pages: 226-233(2020)
- 作者机构：
  
  1.云南中医药大学　基础医学院，昆明　 650500
  2.云南省中医药学分子生物学重点实验室，昆明　 650500
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200307
  CLC： R2-0; R22; R285.5; R284
- Received：07 July 2019，
  
  Published Online：18 October 2019，
  
  Published：20 March 2020
- 稿件说明：
移动端阅览
Zhen-yuan XU, Xiao-ya LI, Ya-qing XU, et al. Research Progress of Butyrate-producing Bacteria in Regulating Intestinal Microecology and Interventional Effect of Chinese Herbal Medicine[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(6): 226-233.
DOI：

Zhen-yuan XU, Xiao-ya LI, Ya-qing XU, et al. Research Progress of Butyrate-producing Bacteria in Regulating Intestinal Microecology and Interventional Effect of Chinese Herbal Medicine[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(6): 226-233. DOI： 10.13422/j.cnki.syfjx.20200307.

摘要

产丁酸菌是以丁酸为主要代谢产物的一类肠道细菌，其中绝大多数为厚壁菌门，产丁酸菌能够利用膳食中不易消化的碳水化合物合成丁酸，进而通过给肠上皮细胞供能、影响肠黏膜屏障、调整肠道菌群结构、调节宿主免疫等生物功能调节肠道微生态，维持肠道内环境，从而达到改善肥胖、高血压等多种疾病的作用。因此，对产丁酸菌及丁酸的靶向调控成为防治多种人体疾病的潜在重要方法。中药经口服后进入体内首先和胃肠道接触，其与寄生于肠道黏膜上的微生物之间的相互作用是无可避免的重要环节。中药能够调节肠道菌群已得到证实，且中药由于组分复杂、成分众多可以以多层次、多途径、多靶点的方式发挥干预作用。其对产丁酸菌的作用主要体现在中药进入肠道后可起到“益生元”作用，富集有益的产丁酸菌，且中药多糖可作为发酵底物促进丁酸的合成，进而实现对产丁酸菌及丁酸的有效调节。基于此，本文探索了产丁酸菌及丁酸与肠道微生态之间的联系，并综述近几年中药干预产丁酸菌调节肠道微生态的相关研究，以期为中医药防治疾病及药物研发提供新的研究思路。

Abstract

Butyrate-producing bacteria are specific intestinal bacteria with butyrate as the main metabolite

and most of them are

Firmicutes

.Butyrate-producing bacteria can synthesize butyrate with non-digestible carbohydrates in the diet

and then regulate intestinal microecology and microenvironment

thereby supplying energy to intestinal epithelial cells

affecting intestinal mucosal barrier

adjusting intestinal flora structure and regulating host immunity

so as to alleviate obesity

hypertension and other diseases.Therefore

the targeted regulation of butyrate-producing bacteria and butyrate has become a potential vital method for the prevention and treatment of many diseases.After oral administration

Chinese herbal medicine (CHM) enters the body

and first contacts gastrointestinal tract

so the interaction between CHM and microbiota existing in the intestine is an inevitable important process.It has been confirmed that CHM could regulate intestinal flora; and due to its complex composition and numerous components

CHM can exert interventional effects at multiple levels

in multiple pathways and on multiple targets.Its effect on the butyrate-producing bacteria is as follows.In the intestinal tract

CHM can play a " prebiotic" role

and enrich the beneficial butyrate-producing bacteria

and polysaccharides in CHM can be used as a fermentation substrate to promote the synthesis of butyrate

so as to achieve the effective regulation of butyrate-producing bacteria and butyrate.Based on that

this paper explored the relationship among butyrate-producing bacteria

butyrate and intestinal microecology

and reviewed relevant researches about the intervention of CHM on butyrate-producing bacteria to regulate intestinal microecology in recent years

in order to provide new research ideas for the application of CHM to prevent and treat diseases

as well as drug development.

关键词

Keywords

references

P D CANI , HUL M VAN , C LEFORT ， et al . Microbial regulation of organismal energy homeostasis [J]． Nature Metabolism ， 2019 ， 1 ( 1 ): 34 - 46 .

王爱华．丁酸钠的生理功能及其在畜禽生产中的应用 [J]．中国饲料， 2014 , 24 : 23 - 26 .

欧则民，吉燕华，孙青云，等．超高效合相色谱法检测短链脂肪酸的研究展望 [J]．中国实验方剂学杂志， 2019 ， 25 ( 10 ): 205 - 213 .

于卓腾，杭苏琴，姚文，等．肠道产丁酸细菌及其丁酸产生机制的研究进展 [J]．世界华人消化杂志， 2006 ， 14 ( 25 ): 2531 - 2534 .

董锦忠，宋吉宁，刘浩明．老年非小细胞肺癌患者和肠道产丁酸菌的相关性研究 [J]．临床肺科杂志， 2018 ， 23 ( 11 ): 1974 - 1977 .

L PETRA , G L HOLD , H J FLINT ． The gut microbiota, bacterial metabolites and colorectal cancer [J]． Nat Rev Microbio ， 2014 ， 12 ( 10 ): 661 - 672 .

X FU , Z LIU , C ZHU ， et al . Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria [J]． Crit Rev Food Sci Nutr ， 2019 ， 59 ( sup1 ): S130 - S152 .

L BENEVIDES , S BURMAN , R MARTIN ， et al . New Insights into the diversity of the genus faecalibacterium [J]． Front Microbiol ， 2017 ， doi: 10.3389/fmicb.2017.01790 http://dx.doi.org/10.3389/fmicb.2017.01790 .

H LI , Y GONG , Y XIE ， et al . Clostridium butyricum protects the epithelial barrier by maintaining tight junction protein expression and regulating microflora in a murine model of dextran sodium sulfate-induced colitis [J]． Scand J Gastroenterol ， 2018 ， 53 ( 9 ): 1031 - 1042 .

Y WANG , Y GU , K FANG ， et al . Lactobacillus acidophilus and Clostridium butyricum ameliorate colitis in murine by strengthening the gut barrier function and decreasing inflammatory factors [J]． Benef Microbes ， 2018 ， 9 ( 5 ): 775 - 787 .

赵怀宝，任玉龙．结肠微生物菌群代谢产物的研究进展 [J]．饲料研究， 2019 ， 42 ( 5 ): 93 - 97 .

缪丽燕，丁肖梁．肠道菌群与精准药物治疗 [J]．医学研究生学报， 2019 ， 32 ( 5 ): 474 - 478 .

M A R VINOLO , H G RODRIGUES , E HATANAKA ， et al . Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils [J]． J Nutr Biochem ， 2011 ， 22 ( 9 ): 849 - 855 .

芦娜，王恬，钟翔．不同的丁酸产品在猪禽生产中的应用研究进展 [J]．动物营养学报， 2015 ， 27 ( 2 ): 359 - 368 .

L DONG , X ZHONG , J HE ， et al . Supplementation of tributyrin improves the growth and intestinal digestive and barrier functions in intrauterine growth-restricted piglets [J]． Clin Nutr ， 2016 ， 35 ( 2 ): 399 - 407 .

H LIU , J WANG , T HE ， et al . Butyrate: a double-edged sword for health？ [J]． Adv Nutr ， 2018 ， 9 ( 1 ): 21 - 29 .

B L CANTAREL , V LOMBARD , B HENRISSAT ． Complex carbohydrate utilization by the healthy human microbiome [J]． PLoS One ， 2012 ， 7 ( 6 ): e28742 .

刘松珍，张雁，张名位，等．肠道短链脂肪酸产生机制及生理功能的研究进展 [J]．广东农业科学， 2013 ， 40 ( 11 ): 99 - 103 .

J WHITT , V WOO , P LEE ， et al . Disruption of Epithelial HDAC3 in intestine prevents diet-induced obesity in mice [J]． Gastroenterology ， 2018 ， 155 ( 2 ): 501 - 513 .

袁榴翼，李小锦，尹清晟，等．中药干预肠道菌群改善肠黏膜屏障功能的研究进展 [J]．中草药， 2018 ， 49 ( 8 ): 1932 - 1938 .

邓昌玉，张乐，蓝程，等．肠黏膜生物屏障与肠易激综合征的治疗 [J]．检验医学与临床， 2015 ， 12 ( 16 ): 2473 - 2475 .

陈润泽，李鹏飞，胡雨奇，等．肠道菌群在中药代谢中的作用 [J]．中国微生态学杂志， 2018 ， 30 ( 8 ): 128 - 131 .

P LUYING , Z R LI , R S GREEN ， et al . Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers [J]． J Nutr ， 2009 ， 139 ( 9 ): 1619 .

W MIAO , X WU , K WANG ， et al . Sodium butyrate promotes reassembly of tight junctions in Caco-2 monolayers involving inhibition of MLCK/MLC2 pathway and phosphorylation of PKC β 2 [J]． Int J Mol Sci ， 2016 ， 17 ( 10 ): 1696 .

H HATAYAMA , J IWASHITA , A KUWAJIMA ， et al . The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T [J]． Biochem Biophys Res Commun ， 2007 ， 356 ( 3 ): 599 - 603 .

W FENG , Y WU , G CHEN ， et al . Sodium butyrate attenuates diarrhea in weaned piglets and promotes tight junction protein expression in colon in a GPR109A-dependent manner [J]． Cell Physiol Biochem ， 2018 ， 47 ( 4 ): 1617 - 1629 .

L ZHENG , C J KELLY , K D BATTISTA ， et al . Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of Claudin-2 [J]． J Immunol ， 2017 ， 199 ( 8 ): 2976 - 2984 .

J LEE , Y S JANG , M J HAN ， et al . Deciphering Clostridium tyrobutyricum metabolism based on the whole-genome sequence and proteome analyses [J]． MBio ， 2016 ， 7 ( 3 ): e00743 - e00716 .

Y FENG , Y WANG , P WANG ， et al . Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy [J]． Cell Physiol Biochem ， 2018 ， 49 ( 1 ): 190 - 205 .

J L FACHI , J S FELIPE , L P PRAL ， et al . Butyrate protects mice from clostridium difficile-induced colitis through an HIF-1-dependent mechanism [J]． Cell Rep ， 2019 ， 27 ( 3 ): 750 - 761 .

J YE , L LV , W WU ， et al . Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels [J]． Front Microbiol ， 2018 ， doi: 10.33897/fmicb.2018.01967 http://dx.doi.org/10.33897/fmicb.2018.01967 .

M X BYNDLOSS , E E OLSAN , F RIVERA-CHAVEZ ， et al . Microbiota-activated PPAR-gamma signaling inhibits dysbiotic enterobacteriaceae expansion [J]． Science ， 2017 ， 357 ( 6351 ): 570 - 575 .

刘锐钢，肖英平，陈安国．丁酸盐的生物学功能和机制及其在动物生产中的应用 [J]．动物营养学报， 2013 ， 25 ( 6 ): 1180 - 1188 .

M M HOSSAIN , M BEGUM , I H KIM ． Effect of Bacillus subtilis, Clostridium butyricum and Lactobacillus acidophilus endospores on growth performance, nutrient digestibility, meat quality, relative organ weight, microbial shedding and excreta noxious gas emission in broilers [J]． Vet Med ， 2015 ， 60 ( 2 ): 77 - 86 .

韩金凤，彭豫东，贺建华，等．丁酸梭菌对家禽肠道屏障功能的影响 [J]．广东饲料， 2017 ， 26 ( 4 ): 28 - 29 .

D B SILK , A DAVIS , J VULEVIC ， et al . Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome [J]． Aliment Pharmacol Ther ， 2009 ， 29 ( 5 ): 508 - 518 .

S D ZUMBRUN , A R MELTON-CELSA , M A SMITH ， et al . Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157：H7 colonization and disease [J]． Proc Natl Acad Sci USA ， 2013 ， 110 ( 23 ): E2126 - E2133 .

P GONCALVES , J R ARAUJO , J P DI SANTO ． A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease [J]． Inflamm Bowel Dis ， 2018 ， 24 ( 3 ): 558 - 572 .

A K DEGRUTTOLA , D LOW , A MIZOGUCHI ， et al . Current understanding of dysbiosis in disease in human and animal models [J]． Inflamm Bowel Dis ， 2016 ， 22 ( 5 ): 1137 - 1150 .

A D KOSTIC , R J XAVIER , D GEVERS ． The microbiome in inflammatory bowel disease: current status and the future ahead [J]． Gastroenterology ， 2014 ， 146 ( 6 ): 1489 - 1499 .

J PARK , M KIM , S G KANG ， et al . Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway [J]． Mucosal Immunol ， 2015 ， 8 ( 1 ): 80 - 93 .

M ZHANG , Q ZHOU , R G DORFMAN ， et al . Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats [J]． BMC Gastroenterol ， 2016 ， 16 ( 1 ): 84 .

M KIM , Y QIE , J PARK ， et al . Gut microbial metabolites fuel host antibody responses [J]． Cell Host Microbe ， 2016 ， 20 ( 2 ): 202 - 214 .

王柳懿，李海花，李玉鹏，等．丁酸梭菌对仔猪回肠免疫信号通路相关蛋白和血清细胞因子的影响 [J]．中国畜牧杂志， 2017 ， 53 ( 8 ): 84 - 88 .

冉舒文，慕春龙，朱伟云．丁酸抑制溃疡性结肠炎分子机制的研究进展 [J]．世界华人消化杂志， 2018 ， 26 ( 14 ): 856 - 861 .

E C AGUILAR , A J LEONEL , L G TEIXEIRA ， et al . Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFkappaB activation [J]． Nutr Metab Cardiovasc Dis ， 2014 ， 24 ( 6 ): 606 - 613 .

M S VERMA , M J FINK , G L SALMON ， et al . A common mechanism links activities of butyrate in the colon [J]． ACS Chem Biol ， 2018 ， 13 ( 5 ): 1291 - 1298 .

J SCHULTHESS , S PANDEY , M CAPITANI ， et al . The short chain fatty acid butyrate imprints an antimicrobial program in macrophages [J]． Immunity ， 2019 ， 50 ( 2 ): 432 - 445 .

Y FURUSAWA , Y OBATA , S FUKUDA ， et al . Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells [J]． Nature ， 2013 ， 504 ( 7480 ): 446 - 450 .

X ZENG , X GAO , Y PENG ， et al . Higher risk of stroke is correlated with increased opportunistic pathogen load and reduced levels of butyrate-producing bacteria in the gut [J]． Front Cell Infect Microbiol ， 2019 ， 9 : 4 .

T YANG , K L MAGEE , L M COLON-PEREZ ， et al . Impaired butyrate absorption in the proximal colon, low serum butyrate and diminished central effects of butyrate on blood pressure in spontaneously hypertensive rats [J]． Acta Physiol (Oxf) ， 2019 ， 226 ( 2 ): e13256 .

Y F QI , J N SUN , L F REN ， et al . Intestinal microbiota is altered in patients with gastric cancer from shanxi province, China [J]． Dig Dis Sci ， 2019 ， 64 ( 5 ): 1193 - 1203 .

J WHITT , V WOO , P LEE ， et al . Disruption of epithelial HDAC3 in intestine prevents diet-induced obesity in mice [J]． Gastroenterology ， 2018 ， 155 ( 2 ): 501 - 513 .

B SUN , Y JIA , J HONG ， et al . Sodium Butyrate ameliorates high-fat-diet-induced non-alcoholic fatty liver disease through peroxisome proliferator-activated receptor alpha-mediated activation of beta oxidation and suppression of inflammation [J]． J Agric Food Chem ， 2018 ， 66 ( 29 ): 7633 - 7642 .

V SINGH , B S YEOH , R E WALKER ， et al . Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation [J]． Gut ， 2019 ， doi: 10.1136/gutjnl-2018-316250 http://dx.doi.org/10.1136/gutjnl-2018-316250 .

L A BIONDO , A A S TEIXEIRA , L S SILVEIRA ， et al . Tributyrin in inflammation: does white adipose tissue affect colorectal cancer？ [J]． Nutrients ， 2019 ， doi: 10.3390/nu11010110 http://dx.doi.org/10.3390/nu11010110 .

M SERINO ． SCFAs-the thin microbial metabolic line between good and bad [J]． Nat Rev Endocrinol ， 2019 ， 15 ( 6 ): 318 - 319 .

杜珊，周月，陈斌．中医药与肠道微生态相关性研究进展 [J]．中国实验方剂学杂志， 2019 ， 25 ( 18 ): 182 - 188 .

杨淑婷，陈思颖，孙慧园，等．大鼠肠道菌群对荭草花有效组分代谢转化的影响 [J]．中国实验方剂学杂志， 2019 ， 25 ( 14 ): 142 - 149 .

辜沅，舒青龙．多糖利用位点研究进展及其在中药药理研究中的应用 [J]．中国实验方剂学杂志， 2019 ， 25 ( 16 ): 193 - 200 .

Y KANG , G YANG , S ZHANG ， et al . Goji berry modulates gut microbiota and alleviates colitis in IL-10-deficient mice [J]． Mol Nutr Food Res ， 2018 ， 62 ( 22 ): e1800535 .

H ZENG , C HUANG , S LIN ， et al . Lotus seed resistant starch regulates gut microbiota and increases short-chain fatty acids production and mineral absorption in mice [J]． J Agric Food Chem ， 2017 ， 65 ( 42 ): 9217 - 9225 .

I MARTINEZ , J KIM , P R DUFFY ， et al . Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects [J]． PLoS One ， 2010 ， 5 ( 11 ): e15046 .

A W WALKER , J INCE , S H DUNCAN ， et al . Dominant and diet-responsive groups of bacteria within the human colonic microbiota [J]． ISME J ， 2011 ， 5 ( 2 ): 220 - 230 .

S S SUN , K WANG , K MA ， et al . An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota [J]． Chin J Nat Med ， 2019 ， 17 ( 1 ): 3 - 14 .

S XIAO , Z ZHANG , M CHEN ， et al . Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism [J]． J Ethnopharmacol ， 2019 ， 241 : 112032 .

U ETXEBERRIA , N ARIAS , N BOQUE ， et al . Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats [J]． J Nutr Biochem ， 2015 ， 26 ( 6 ): 651 - 660 .

L CHEN , B JIANG , C ZHONG ， et al . Chemoprevention of colorectal cancer by black raspberry anthocyanins involved the modulation of gut microbiota and SFRP2 demethylation [J]． Carcinogenesis ， 2018 ， 39 ( 3 ): 471 - 481 .

Y M YAN , Y J PENG , J L TANG ， et al . Effects of anthocyanins from the fruit of Lycium ruthenicum Murray on intestinal microbiota [J]． J Funct Foods ， 2018 ， 48 : 533 - 541 .

刘洪毓，张亚男，李自辉，等．基于“入腹知性”理论的黄芩干预大鼠肠道菌群多样性的探讨 [J]．中国实验方剂学杂志， 2019 ， 25 ( 18 ): 167 - 173 .

李自辉，庞牧，林佩锜，等．基于16S rRNA技术分析柴胡龙骨牡蛎汤对精神分裂症大鼠肠道菌群多样性的影响 [J]．中国实验方剂学杂志， 2019 ， 25 ( 13 ): 1 - 8 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Characteristics and Regulatory Mechanisms of Cholestatic Liver Injury Caused by Chinese Herbal Medicines

Effect of Intestinal Microecology on Diabetic Kidney Disease Based on Yin-Yang Theory

Toxicity Reduction Measures of Herbal Medicines Causing Liver Injury and Role of Herbal Medicines in Preventing and Treating Liver Injury

Role of Imbalance of "Gut-Host Immunity" in Diabetic Macroangiopathy： An Exploration Based on Theory of "Superabundance of Yangming"

Changes in Diversity of Intestinal Butyrate-producing Bacteria During Treatment with Shenling Baizhusan and Lizhongtang in Animal Model of AAD

Related Author

YANG Yifei

LIU Ting

YANG Yun

ZHANG Guozhuang

MO Chao

HUANG Guodong

SHI Wei

ZHAO Jie

Related Institution

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

Graduate School， Hunan University of Chinese Medicine

Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine

The First Affiliated Hospital of Guangxi University of Chinese Medicine

Graduate School， Guangxi University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰